CClinicalTrials.gg
CompletedNCT01103297VALCP2010Updated Sep 19, 2014

2.4 mm Variable Angle LCP Two-Column Volar Distal Radius

A Phase 4 interventional study of Variable Angle Distal Radius Plate ® (Surgery) in Distal Radius Fractures, sponsored by AO Clinical Investigation and Publishing Documentation. Completed at 6 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-09-19.

Sponsored by AO Clinical Investigation and Publishing Documentation · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
74
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to is to evaluate the postoperative loss of reduction rate in patients with distal radius fractures treated using the 2.4 mm Variable Angle LCP Two-Column Volar Distal Radius Plate ®.

Read the detailed description

The treatment of choice for distal radius fractures is anatomic reduction with stable fixation. This is commonly achieved via open reduction and internal fixation with angle-stable designed locking plates using either a volar or dorsal approach. Frequent complications of tendinitis are associated with the latter approach. Palmar application of angle-stable plates reduces this problem of extensor tendon irritation; however a high incidence of fracture collapse has been documented. Currently, there are no existing locking plates that provide sufficient stability particularly for complex fractures. Insufficient fragment fixation can result in loss of reduction due to interfragmentary movement and lead to mal- or nonunion.

The Variable Angle LCP Two-Column Volar DR plate (VA LCP DR) is a novel development of the LCP Distal Radius Plate System, which is designed to treat a wide variety of distal radius fracture patterns. Because of its design (ie, low plate and screw profile, polished surface, rounded edges, various locking options), not only can the potential for tendon adhesions and soft tissue irritation be minimized, the plate can address fragments individually for each fracture type. Thus, the versatility of VA LCP facilitates the reduction and stabilization of even the most complex fractures, including those in osteoporotic bone.

This prospective case-series will evaluate the performance of the new VA LCP DR plate in the treatment of complex articular fractures of the distal radius. The primary objective of this study involves the documentation of postoperative loss of reduction; functional outcomes, quality of life and rate of complications associated with fracture fixation will also be assessed as part of the secondary study aims.

02

Conditions studied

  • Distal Radius Fractures

Keywords

  • Distal radius fracture
  • Double row plate
  • Volar approach
  • DVR plate
  • Postoperative complications [MeSH]
03

In context

Radius Fractures

272 studies on the registry are indexed under Radius Fractures; 35 are open to participants now.

This study's enrollment of 74 is above the median of 60 across 218 interventional studies indexed under Radius Fractures.

Browse Radius Fractures studies →

Lead sponsor

AO Clinical Investigation and Publishing Documentation is the lead sponsor of 49 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged ≥ 18 years
  • Patients with closed, partial or complete articular distal radius fractures classified as: AO 23 B3 and AO 23 C1, C2, C3 confirmed by CT scan
  • Definitive primary fracture treatment with a VA LCP DR
  • The patient is willing and able to participate in the study follow-up examinations according to the protocol
  • The patient is able to understand and read the local language at an elementary level
  • The patient or his/her legal guardian is willing and able to give his informed consent to participate in the study
  • Woman must be one of the following:
  • Postmenopausal defined as amenorrhea for at least 6 months before screening and a serum follicle stimulating hormone (FSH) level consistent with postmenopausal status
  • Surgically sterile, (have had a hysterectomy or bilateral oophorectomy, tubal ligation, or otherwise be incapable of pregnancy)
  • Abstinent (at the discretion of the investigator) or,
  • If sexually active, be practicing an effective method of birth control such as hormonal prescription oral contraceptives, progesterone implants or injections, intrauterine device (IUD), a double-barrier method such as condoms, diaphragms or cervical caps with spermicidal foam, cream or gel, or male partner with a vasectomy.
  • Women of childbearing potential must have a negative serum β-human chorionic gonadotropin (β-hCG) pregnancy test, or a negative urine pregnancy test at screening.

Exclusion criteria

Exclusion Criteria:

  • Previous ipsilateral distal radius fracture
  • Other fractures of the ipsilateral side (except ulna)
  • Pathologic fracture due to malignancy
  • The patient suffers from a polytrauma
  • The patient is affected by drug or alcohol abuse
  • The patient suffers from active malignancy
  • Neurological and psychiatric disorders
  • The patient has participated in any other device or drug related clinical trial within the previous month
  • The patient is a prisoner
  • Breast feeding woman
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
74 participants (actual)

Study arms

  • Other
    Variable Angle Distal Radius Plate

    Device: Variable Angle Distal Radius Plate ® (Surgery)

Interventions

  • DeviceVariable Angle Distal Radius Plate ® (Surgery)

    Fracture reduction with distal radius plate

    Also known as: 2.4 Variable Angle LCP Two-Column Volar Distal Radius Plate®

06

What researchers measure

Primary outcomes

  1. Loss of reduction

    Loss of reduction will be defined as the change in measurement\* determined to 0.5 mm or 1 degree of accuracy: \*Any change in angles, length or secondary fragment displacement (ie, radial height (length), radial inclination, ulnar variance, gap, step-off, palmar tilt (inclination) / dorsal tilt, scapholunate angle, teardrop angle, and the AP distance).

    Time frame: over 1 year

Secondary outcomes

  1. Rate of fracture fixation complications

    Time frame: Baseline

  2. Wrist function

    Bilateral Range of motion (ROM)

    Time frame: 12 weeks

  3. Grip strength

    With Jamar dynamometer

    Time frame: 12 weeks

  4. Wrist pain and disability in functional activities

    Patient self-assessment of wrist function questionnaire (PRWE)

    Time frame: Baseline

  5. Quality of Life

    Health-related quality of life (EQ5D)

    Time frame: Baseline

  6. Implantation and system feedback

    Time frame: Baseline

  7. Rate of fracture fixation complications

    Time frame: 12 weeks

  8. Rate of fracture fixation complications

    Time frame: 1 year

  9. Wrist function

    Bilateral Range of motion (ROM)

    Time frame: 1 year

  10. Grip strength

    With Jamar dynamometer

    Time frame: 1 year

  11. Wrist pain and disability in functional activities

    Patient self-assessment of wrist function questionnaire (PRWE)

    Time frame: 12 weeks

  12. Wrist pain and disability in functional activities

    Patient self-assessment of wrist function questionnaire (PRWE)

    Time frame: 1 year

  13. Quality of Life

    Health-related quality of life (EQ5D)

    Time frame: 12 weeks

  14. Quality of Life

    Health-related quality of life (EQ5D)

    Time frame: 1 year

07

Study locations

6 sites
  • Unfallkrankenhaus Graz
    Graz, 8020, Austria
  • Charite Berlin
    Berlin, Germany
  • Universitätssklinikum Münster
    Münster, 48149, Germany
  • Universitätsspital Basel
    Basel, 4056, Switzerland
  • Luzerner Kantonsspital
    Luzern, 6000, Switzerland
  • Spital Zollikerberg
    Zürich, 8008, Switzerland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01103297
Lead sponsor
AO Clinical Investigation and Publishing Documentation
Responsible party
Sponsor
First posted
Apr 14, 2010
Start date
Jun 2010
Primary completion
Feb 2014
Completion
May 2014
Last update
Sep 19, 2014

Study contacts

Jesse B Jupiter, MD
principal investigator · Massachusetts General Hospital, Orthopaedic Surgery, Yawkey Center, Suite 2100, 55 Fruit Street, Boston, MA 02114, USA
Andreas Schierz, MD
principal investigator · Spital Zollikerberg, Unfallchirurgie, Trichtenhauserstrasse 20, CH-8125 Zollikerberg, Switzerland

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion